Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
IPSC on Nasdaq
Shares outstanding
87,670,044
Price per share
$2.30
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
25,621,379
Total reported value
$25,478,992
% of total 13F portfolios
0%
Share change
+4,029,804
Value change
+$6,422,848
Number of holders
45
Price from insider filings
$2.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $16,997,172 17,944,649 RA Capital Management, L.P. 09 Jan 2026
TCG Crossover GP II, LLC 9.9% $15,978,987 17,754,430 Chen Yu 09 Jan 2026
Deep Track Capital, LP 7.3% $12,137,760 13,486,400 Deep Track Capital, LP 08 Jan 2026
Venrock Healthcare Capital Partners III, L.P. 7.1% +48% $12,354,782 +$8,606,536 13,043,478 +230% Venrock Healthcare Capital Partners III, L.P. 09 Jan 2026
Commodore Capital LP 7.1% $12,354,782 13,043,478 Commodore Capital LP 09 Jan 2026
Point72 Asset Management, L.P. 6.8% $12,817,360 5,961,563 Point72 Asset Management, L.P. 23 Dec 2025
Bain Capital Life Sciences Opportunities III, LP 4.1% $1,762,227 3,538,609 Bain Capital Life Sciences Opportunities III, LP 30 Sep 2025
Casdin Capital, LLC 3.7% $1,702,527 3,212,316 Casdin Capital, LLC 31 Mar 2025

As of 31 Dec 2025, 45 institutional investors reported holding 25,621,379 shares of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC). This represents 29% of the company’s total 87,670,044 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Point72 Asset Management, L.P. 6.8% 5,961,631 0.01% $5,930,630
DAFNA Capital Management LLC 3.2% 2,793,586 +64% 0.65% $2,779,059
VANGUARD GROUP INC 2.4% 2,103,869 0% 0% $2,093,350
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.1% 1,838,700 0% $1,829,139
TWO SIGMA INVESTMENTS, LP 1.7% 1,495,916 +64% 0% $1,488,137
Spruce Street Capital LP 1.6% 1,421,532 0% 0.47% $1,414,140
RENAISSANCE TECHNOLOGIES LLC 1.5% 1,349,200 -48% 0% $1,342,184
TWO SIGMA ADVISERS, LP 1.4% 1,267,700 +48% 0% $1,261,108
Casdin Capital, LLC 1.4% 1,228,190 0% 0.08% $1,221,803
ACADIAN ASSET MANAGEMENT LLC 1.4% 1,217,103 +69% 0% $1,209,000
Syncona Portfolio Ltd 1.4% 1,213,056 0% 3.5% $1,206,991
MILLENNIUM MANAGEMENT LLC 0.7% 610,387 -18% 0% $607,213
BlackRock, Inc. 0.69% 601,866 +0.37% 0% $598,737
SUPERSTRING CAPITAL MANAGEMENT LP 0.53% 462,963 0% 0.25% $460,556
GEODE CAPITAL MANAGEMENT, LLC 0.52% 456,115 +2.4% 0% $453,899
GSA CAPITAL PARTNERS LLP 0.38% 333,199 -45% 0.03% $331,000
CITADEL ADVISORS LLC 0.36% 319,457 -11% 0% $317,796
UBS Group AG 0.24% 214,501 +63550% 0% $213,428
STATE STREET CORP 0.15% 127,443 0% 0% $126,780
NORTHERN TRUST CORP 0.12% 105,052 +57% 0% $104,506
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.09% 77,797 -0.07% 0% $70,017
ALGERT GLOBAL LLC 0.09% 76,800 0% $76,000
FMR LLC 0.08% 71,540 -63% 0% $71,168
PRUDENTIAL FINANCIAL INC 0.07% 59,800 0% 0% $59,489
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.06% 50,104 -26% 0% $49,843

Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 25,621,379 $25,478,992 +$6,422,848 $0.99 45
2025 Q3 20,280,322 $10,103,490 -$1,196,912 $0.50 53
2025 Q2 22,628,192 $12,642,486 -$3,582,180 $0.56 64
2025 Q1 29,565,044 $14,071,235 -$4,277,613 $0.48 69
2024 Q4 36,396,514 $36,761,199 -$7,768,598 $1.01 70
2024 Q3 39,649,193 $67,797,499 -$1,211,276 $1.71 66
2024 Q2 40,117,934 $102,301,880 +$40,961,743 $2.55 59
2024 Q1 23,113,173 $96,605,177 +$22,882,584 $4.18 66
2023 Q4 17,675,436 $58,683,678 -$543,594 $3.32 60
2023 Q3 18,060,757 $36,118,983 -$2,770,150 $2.00 53
2023 Q2 19,290,007 $60,957,915 -$2,350,461 $3.16 62
2023 Q1 20,016,851 $69,456,630 -$4,620,580 $3.47 63
2022 Q4 20,893,156 $107,178,277 -$3,631,215 $5.13 65
2022 Q3 21,098,040 $208,661,435 -$4,940,964 $9.89 52
2022 Q2 21,756,667 $182,752,181 -$3,241,178 $8.40 51
2022 Q1 22,151,698 $278,859,136 +$11,504,710 $12.59 51
2021 Q4 21,137,514 $335,200,000 +$24,348,825 $15.86 50
2021 Q3 19,798,633 $496,205,288 +$62,122,502 $25.16 47
2021 Q2 16,881,896 $490,834,435 +$490,834,432 $29.34 35